Open Access

Erratum to: CYP2J3 gene delivery reduces insulin resistance via upregulation of eNOS in fructose-treated rats

Cardiovascular Diabetology201413:17

DOI: 10.1186/1475-2840-13-17

Received: 14 January 2014

Accepted: 14 January 2014

Published: 11 February 2014

The original article was published in Cardiovascular Diabetology 2011 10:114


We deeply regret that we have inadvertently made a minor mistake in our publication [1] and we feel it necessary to correct this error. Following publication of our work, we reviewed all the Western blots of the experiments; all showed an identical trend in terms of scientific interpretation. Unfortunately, it was subsequently noticed that Figure one A (Figure 1 here) (CYP2J3 expression) was not the original unedited (un-cropped) blot, and we would like to correct that inadvertent error. The following Western blot (Figure 1) therefore replaces Figure one A in the original article. We recognize that this Western blot is not as clean, but it clearly presents the original without modifications (cropping) and thus can avoid confusion for the readers. We wish to emphasize that the experiments on CYP2J3 overexpression with Western blot analysis were repeated 4 times, with identical results obtained each time. The error had no effect on the scientific content or conclusions. We deeply apologize that this occurred, and take responsibility for the error and hereby present the correction.
Figure 1

Effects of CYP2J3 gene delivery on CYP2J3 protein expression, plasma and urinary 14,15-DHET levels. CYP2J3 protein levels were increased in aorta, heart, liver and kidney of fructose-treated rats 3 weeks following injection of CYP2J3(+).



Authors’ Affiliations

Department of Internal Medicine and The Institute of Hypertension, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Department of Emergency, Sun Yat-sen Memorial Hospital, Sun Yat-sen University


  1. Xu X, Tu L, Wang L, Fang X, Wang DW: CYP2J3 gene delivery reduces insulin resistance via upregulation of eNOS in fructose-treated rats. Cardiovasc Diabetol. 2011, 10: 114-10.1186/1475-2840-10-114.PubMed CentralView ArticlePubMedGoogle Scholar


© Xu et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.